"/> Novus Biologicals™ Imiquimod, TLR7 ligand | B-LABO France

Novus Biologicals™ Imiquimod, TLR7 ligand

Réf. : BL-RE-167011Réf. fabricant : 18625380 5 mg
343,00 € HT

Applications: Functional, In vitro assay, Ligand Activation

Concentration
2.5 mg/mL
Formule
C14H16N4, HCl
Contenu et stockage
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Quantité
5 mg
À utiliser avec (application)
This product is useful for activation of TLR7 and stimulation of TLR7 has been achieved with 5 to 10μL. Use in ligand activation, functional, and in vitro reported in scientific literature (PMID 25957979)
Marque
Novus Biologicals

Imiquimod, TLR7 ligand is an imidazoquinoline amine analog to guanosine. As a synthetic molecule of the Imidazoquinoline family, it has potent immunostimulatory activity. Imiquimod has been shown to activate only TLR7. This activation is MyD88 dependant and leads to the induction of the transcription factor NF-kB. Buffer: 125μg in 50μL of DMSO (formerly supplied in sterile water) Endotoxin Note: <0.001 EU/μg MW: 276.8

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-167011
Réf. fabricant18625380
Concentration2.5 mg/mL
FormuleC<sub>14</sub>H<sub>16</sub>N<sub>4</sub>, HCl
Contenu et stockageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Quantité5 mg
À utiliser avec (application)This product is useful for activation of TLR7 and stimulation of TLR7 has been achieved with 5 to 10μL. Use in ligand activation, functional, and in vitro reported in scientific literature (PMID 25957979)
CibleImiquimod, TLR7 ligand
EspècesHuman/Mouse
Une question, une configuration particulière ?
Contactez-nous pour un devis.